In line with our data Lin et al. reported a significant increase of CD4+Foxp3+ T cells in patients with active SLE, determined by the SLEDAI score, as compared to patients with inactive SLE or HC. This evidence concerns the gene FOXP3 and systemic lupus erythematosus.